This Fund Exited a $5 Million DNOW Stake Last Quarter. The Stock Has Fallen 12% This Year

Quantedge Capital sold its entire 351,310-share DNOW position on Feb 17, 2026, disposing of roughly $5.36M and exiting a stake that had represented 2.9% of the fund’s AUM. DNOW shares traded at $11.79, down ~27% over the past year and ~12% YTD in 2026; company TTM revenue is $2.8B with a $89M net loss and >$200M adjusted EBITDA. The exit underscores investor caution around execution risk from the MRC Global acquisition and ERP integration, likely reinforcing negative sentiment toward the energy-distribution name.

Analysis

ERP-driven execution risk in capital-goods distribution creates stress in two levers that the market prices quickly: working-capital swings and lost fill-rates that depress both revenue growth and gross margins. Expect receivables and inventory days to oscillate for 2–4 quarters as systems settle; each 10–15 day deterioration in net working capital will likely convert into a visible hit to free cash flow and force short-term liquidity responses (discounting, vendor pay slowdowns).

Second-order winners are scale operators with clean IT footprints and less cyclical end-markets — they can selectively extend credit and pick off orders when a peer’s service levels slip, capturing incremental margin without incremental capex. Conversely, smaller regional distributors and OEMs tied to the same energy project cadence will see an indirect slowdown in parts flow and aftermarket replacement cycles, depressing supplier order books for 1–3 quarters.

Key catalysts to watch are operational (AR days, fill-rate, margin stabilization) rather than top-line guidance alone; a quarter-over-quarter improvement in AR days of 10–15% or a 200–300bp rebound in adjusted gross margin would be a positive technical trigger within 3 months. downside tail risks include protracted ERP bugs that force expense recognition, accelerated customer churn, or covenant pressure if capex/working-capital drains persist — any of these would likely induce another leg down within weeks.

From a positioning standpoint, the current repricing creates asymmetric trades: you can express a leveraged view on recovery via time-limited, risk-defined option structures, or express a directional view that execution risk will persist via a funded, pair short. Manage size tightly and use operational data releases (monthly sales, AR) as stop-loss/event triggers rather than calendar-only exits.

Key Decisions for Investors

• Pair trade (3–9 months): Short DNOW ≈1% NAV vs Long BWA ≈1% NAV. Rationale: capture dispersion between an execution-risk distributor and a structurally healthier supplier. Risk: cut if DNOW rallies >25% or BWA falls >10%. Target: 15–30% net return if execution nightmares persist.
• Directional, risk-defined long (6–12 months): Buy DNOW 12-month call spread (buy ATM, sell ~25% OTM) sized to risk 0.5–1.0% NAV. Rationale: limited downside premium with >2x payoff if operations normalize and multiple re-rates. Close or roll if AR days fall by ≥10% in a single quarter.
• Straight long (6–12 months): Accumulate BWA on pullbacks (add on intraday weakness >8%) to ~2% NAV. Rationale: defensive industrial exposure and positive positioning vs short distributors. Target 25–40% upside; stop -8–10% from entry.
• Event hedge / volatility play (0–3 months): Buy near-dated DNOW puts or a put calendar to protect funded shorts or long exposure around next monthly operational update. Rationale: protect against earnings/ERP-news-driven gap moves. Keep this hedge cheap-sized (0.25–0.5% NAV) and trim if realized volatility spikes >40%.